During the third quarter, KeyBank National Association OH increased its holdings in LyondellBasell Industries N.V. by 234.7%, acquiring an additional 35,841 shares to reach a total position of 51,109 shares valued at approximately USD 2.5 million. This surge contrasts with more modest adjustments by other institutional investors: New York Life Investment Management added 193 shares in Q2, State of Michigan Retirement System added 200 shares, Cooper Financial Group purchased 211 shares in Q3, and U.S. Capital Wealth Advisors added 241 shares. Overall, hedge funds and institutional investors now control 71.2% of the company’s outstanding equity, underlining strong confidence in the specialty chemicals leader’s strategic positioning and cash-flow generation.

In its fourth-quarter report, LyondellBasell Industries posted a revenue decline of 9.2% year-over-year to USD 7.09 billion, while reporting a loss per share of USD 0.26 versus consensus expectations for a modest profit. The company attributed the downturn to weak demand in olefins and polyolefins markets and sustained feedstock cost inflation. Net margins swung negative at –2.5%, compared with positive returns in prior periods, and return on equity slipped to 4.9%. Management signaled that continued volatility in feedstock spreads and global polymer consumption could persist into the first half of 2026.

LyondellBasell maintained its quarterly payout, distributing USD 1.37 per share in December for an annualized yield of roughly 10.9%. This reflects a payout ratio of –235%, driven by the recent earnings shortfall. Meanwhile, Executive Vice President Kimberly A. Foley acquired 5,661 shares in November, boosting her personal stake by 9.1% to 67,688 shares. The insider purchase underscores management’s view of the company’s long-term earnings recovery potential despite near-term market headwinds.

Analyst sentiment toward LyondellBasell remains mixed. Two firms rate the shares a Buy, 17 maintain Hold recommendations and five issue Sell opinions. Consensus target prices cluster in the mid-$40 to low-$50 range, implying limited upside from current levels. Recent broker actions include both target upgrades and downgrades, reflecting divergent views on the timing and magnitude of margin recovery. The stock now trades at a forward price-to-earnings multiple in line with or modestly above sector averages, a reversal from its historical discount, as earnings expectations for 2026 have been revised downward while valuation multiples have stabilized.